• All sections
  • A - Human necessities
  • A61K - Preparations for medical, dental or toiletry purposes
  • A61K 47/55 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds

Patent holdings for IPC class A61K 47/55

Total number of patents in this class: 1429

10-year publication summary

11
42
77
140
153
162
188
273
249
66
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

Principal owners for this class

Owner
All patents
This class
Purdue Research Foundation
3277
36
Dana-Farber Cancer Institute, Inc.
2455
35
Yale University
2204
32
Sapreme Technologies B.V.
74
32
The Regents of the University of California
18943
25
Arvinas Operations, Inc.
165
19
Kymera Therapeutics, Inc.
175
15
Zevra Therapeutics, Inc.
85
14
University of Southern California
2016
13
Charite - Universitatsmedizin Berlin
369
10
Elysium Therapeutics, Inc.
16
9
Endocyte, Inc.
113
9
University of Massachusetts
2130
9
Imbria Pharmaceuticals, Inc.
60
9
Diverse Biotech, Inc.
16
9
Uppthera Inc.
11
9
Wisconsin Alumni Research Foundation
3774
8
Elucida Oncology, Inc.
12
8
Icahn School of Medicine at Mount Sinai
859
8
Ripple Therapeutics Corporation
33
8
Other owners 1112